Diagnostics Development Dxd Hub News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostics development dxd hub. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostics Development Dxd Hub Today - Breaking & Trending Today

Singapore enhances neutralizing antibody testing service


Singapore enhances neutralizing antibody testing service
Singapore enhances neutralizing antibody testing service
12 April 2021 | News
Image credit- prnewswire
GenScript Biotech Corporation, Parkway Laboratories and the Diagnostics Development (DxD) Hub announced their collaboration to provide the cPass™ SARS-CoV-2 neutralizing antibody test in Singapore through Parkway s panel of specialist and GP clinics.
Neutralizing antibodies are a small percentage of antibodies that bind to sites on the virus and inhibit entry of that virus into the host. Unlike the many COVID-19 lab-based antibody test kits commercially available, cPass™ can detect functional neutralizing antibodies.
Traditionally, measuring neutralizing antibodies requires the use of live virus, cells, highly skilled operators, and complex laboratory procedures that require several days in the laboratory to obtain results and limit their widespread use. ....

Health Sciences Authority , Diagnostics Development Dxd Hub , Drug Administration , Genscript Biotech Corporation , Parkway Laboratories , Diagnostics Development , Antibody Detection Kit , ஆரோக்கியம் அறிவியல் அதிகாரம் , பரிசோதனை வளர்ச்சி ட்கஷ்ட் மையம் , பரிசோதனை வளர்ச்சி , ஆன்டிபாடி கண்டறிதல் கிட் ,

RESOLUTE 2.0 COVID-19 TEST KIT FIRST TO RECEIVE SINGAPORE HEALTH SCIENCES AUTHORITY'S APPROVAL FOR DEEP THROAT SALIVA TESTING


Share:
APPROVAL ALLOWS
RESOLUTE 2.0 TEST KIT TO BE USED WITH A VARIETY OF TESTING METHODS – INCLUDING DEEP-THROAT SALIVA, OROPHARYNGEAL/MIDDLE TURBINATE AND NASOPHARYNGEAL TEST SWABS
RESOLUTE 2.0 WILL BE USED AT SINGAPORE CHANGI AIRPORT WITH THE NEW ON-SITE ADDITION OF A COVID-19 TESTING LAB IN 2021.
Advanced MedTech Holdings (AMTH), a global medical technology leader headquartered in Singapore, announced today that the RESOLUTE 2.0 test kit has become the first RT-PCR COVID-19 test to be authorised by Singapore s Health Sciences Authority (HSA) for deep-throat saliva (DTS) SARS-CoV-2 testing. 
The clinical performance of DTS is supported by clinical studies involving the Diagnostics Development (DxD) Hub hosted by the Agency for Science, Technology and Research (A STAR); Temasek Foundation; Changi General Hospital (CGH); DSO National Laboratories (DSO); and Woodlands Health Campus (WHC). The tests conducted on DTS specimens were able to accurately ident ....

Singapore General , Singapore Changi Airport , Weikang Lee , Abel Ang , Cheong Chee Hoo , Agency For Science , Singapore Agency For Science Technology , Diagnostics Development Dxd Hub , Temasek Foundation , Singapore Health Sciences Authority , Health Sciences Authority , Medtech Holdings , Spurwing Communications , Woodlands Health Campus , National Laboratories , Diagnostics Development , Changi General Hospital , Changi Airport , Group Chief Executive , Advanced Medtech , Frederick Chew , Chief Executive Officer , Professor Ng Wai Hoe , Advanced Medtech Holdings , Reverse Transcription Polymerase Chain Reaction , Science Technology ,